An anticonvulsant
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Methsuximide

Item No. 19058

Technical Information
Formal Name
1,3-dimethyl-3-phenyl-2,5-pyrrolidinedione
CAS Number
77-41-8
Synonyms
  • (±)-Mesuximide
  • N,2-dimethyl-2-Phenylsuccinimide
  • PM 396
Molecular Formula
C12H13NO2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 25 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:40): 0.02 mg/mlEthanol: 25 mg/ml
SMILES
CN(C(CC1(C)C2=CC=CC=C2)=O)C1=O
InChi Code
InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3
InChi Key
AJXPJJZHWIXJCJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Methsuximide is an anticonvulsant.1 It is a substrate for the cytochrome P450 (CYP) isoform CYP2C19 and inhibits the metabolism of chlorproguanil and proguanil (Item No. 30675) when used at a concentration of 100 µM.2 Methsuximide (100 mg/kg) protects against leptazol-induced convulsions in rats.1 Formulations containing methsuximide have been used in the treatment of petit mal seizures.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nicholls, P.J., and Orton, T.C. The physiological disposition of 14C-methsuximide in the rat. Br. J. Pharmacol. 45(1), 48-59 (1972).

    2. Wright, J.D., Helsby, N.A., and Ward, S.A. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides. Br. J. Clin. Pharmacol. 39(4), 441-444 (1995).